BIOMIT Center for Molecular Immunology - CIM

Abaut us


Obtain and produce new biopharmaceuticals for the treatment of cancer and other chronic noncommunicable diseases and introduce them to the Cuban Public Health. Make the scientific and productive activity economically sustainable and make contributions to the economy of the country.


To be the Latin American and Caribbean company with the greatest impact on the survival of cancer and other chronic noncommunicable diseases and with high corporate responsibility regarding the economy of the country and its stakeholders. Become an international reference biotechnology company developing a business culture of excellence based on innovation, diversification and dedication to work.


The CIM promotes the following values:
· The CIM is a bulwark of the revolution and socialism
· Real and competitive science
· Consecration to work
· Simplicity and accessibility of bosses
· Creative environment
· Transparent debate
· Culture of Quality

Staff and Structures

The CIM on its 25th Anniversary (2019) is an organization of organizations with 1063 workers, where professionals occupy about 50%. It is made up of 5 large, complex and geographically distributed production facilities: Havana (EPOVAC-ANTYTER); Santiago de Cuba (LABEX); Beijing, China (BIOTECH-BPL) and Bangkok, Thailand (ABINIS) increasingly dependent on extramural networks and connected to the National Health System working against a "resistant" market. It has 22 products online and 6 registered products; with 34 patents in Cuba (26 granted), 894 patents filed abroad (591 granted) and more than 500 published articles. It is estimated that in 2018 around 10,000 Cuban patients received some product from the CIM.

Phone Board:
General Direction:
15 Street and 216 Street, Siboney, Playa, La Habana, Cuba. A.P 16040, La Habana 11600, Cuba
Postal Code:
11 600
Post Office Box:
16 040



Frequent Questions

How can I access the therapeutic vaccines against lung cancer?

Cuba has 2 therapeutic vaccines for advanced lung cancer: CIMAvax EGF ® and VAXIRA® (Racotumomab). Both therapeutic vaccines have a health record in the indication of advanced non-small cell lung cancer (NSCLC) stage III and IV, after the first line of chemotherapy. The main clinical benefit of these vaccines has been demonstrated in an increase in survival and improvement in quality of life, as well as a broad safety profile. How to get vaccines? Foreigners should contact the Cuban Medical Services who will evaluate each case as part of a comprehensive patient care program, with commercial value. -Cuban Medical Services. Web page: .; E-mail: Telephone: (537) 209-0977 Fax: (537) 203-1590. You can also make your request for care stating the reason for your request, a medical summary and personal data directly to: International Clinic of the Hermanos Ameijeiras Hospital. Calle San Lázaro # 701 esq. a Belascoaín, Centro Habana, La Habana, C.P: 10400, Cuba. Telephone: (537) 8761029, (537) 8761030, (537) 8761683. Email: International Health Center - La Pradera Calle 15 e / 222 A y 234, Reparto Siboney, Playa Municipality, Havana, Cuba Telephone: (+537) 273 7467 Ext. 403 (+537) 2737202. Email:   If you want a treatment outside of Cuba. You can contact the following companies with commercial rights in the region for CIMAvax EGF® DELTA Laboratories S.A. Colombia. General Manager: Mr. Alejandro Castaño. Address: Cra. 46 # 19 Sur 117 Medellín, Colombia, South America. Tel. + 57-4-334 40 33. Cell: +57 - 311-301 8257 E-mail: Skype: Alejandrodelta. URL:   Libra Laboratorios, Paraguay S.A Commercial Manager: Mr. Pablo Moreira. Address: Pedro Ciancio 1443 between Santiago and San Cosme B Jara Asunción Tel. (595-21) 228 370. Cell: (595) 986 679300 E-mail:

Mas preguntas frecuentes...


Welcome to the CIM survey, we value your opinion and thank you for dedicating your time

We would love to know how you like our site
50% (22897 votes)
Very Good
32% (14763 votes)
5% (2686 votes)
11% (5099 votes)
0% (280 votes)